TSE:4548Pharmaceuticals
Seikagaku (TSE:4548) Quarterly Profit Of ¥890m Tests Bearish Margin Narratives
Seikagaku (TSE:4548) has reported Q3 2026 revenue of ¥9.0b and basic EPS of ¥16.30, with the latest trailing twelve month figures showing revenue of ¥35.9b and a loss per share of ¥13.83. The company has seen quarterly revenue move between ¥8.7b and ¥10.2b over the past six reported periods, while basic EPS has ranged from a loss of ¥34.34 per share to a profit of ¥21.20 per share, giving investors a wide spread of outcomes on profitability. With the shares trading around ¥698 and the...